Positions

Overview

  • I am originally from Southern part of India and came to Duke University to study for my Ph.D. in Biochemistry. I was very lonely at Duke and went through a major cultural shock — my English was not fluent and also, because I am a vegetarian, I didn’t know what or where to eat. I transferred to Southern Illinois University and worked with an outstanding scientist and very friendly group of graduate students. I received my Ph.D. in Biochemistry there; my project dealt with organisms and mechanisms responsible for corn stalk rotting.

    After completion of my Ph.D., I moved to Birmingham to apply my carbohydrate knowledge to immunoglobulins. My postdoctoral advisor was an accomplished immunologist and an outstanding advisor. Since coming to UAB I have developed several methods to purify antibodies and quantitate cancer burden in mice. I have enjoyed my stay in Birmingham so much so that I never want to leave. Now, after many years of research, I enjoy teaching immunology, the biology of aging, and evolutionary medicine.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2015 Effects of the dietary ω3:ω6 fatty acid ratio on body fat and inflammation in zebrafish (Danio rerio)Laboratory Animal Science.  65:289-294. 2015
    2010 XIAP-mediated protection of H460 lung cancer cells against cisplatinEuropean Journal of Pharmacology.  627:75-84. 2010
    2009 Molecules involve in the self-protection of neurons against glucose-oxygen-serum deprivation (GOSD)-induced cell damageBrain Research Bulletin.  79:169-176. 2009
    2008 Ischemic brain cell-derived conditioned medium protects astrocytes against ischemia through GDNF/ERK/NF-kB signaling pathwayBrain Research.  1239:24-35. 2008
    2003 Cytokine and hormone profiles in mice subjected to handling combined with rectal temperature measurement stress and handling only stressLife Sciences.  72:1495-1508. 2003
    2003 The phytoestrogen genistein suppresses cell-mediated immunity in miceJournal of Endocrinology.  176:267-274. 2003
    2001 Effects of rotational stress of different duration on NK cell activity, proinflammatory cytokines, and POMC-derived peptides in miceNeuroimmunomodulation.  9:34-40. 2001
    2000 Immunotherapy of a murine T cell lymphoma localized to the brainJournal of Neuro-Oncology.  47:1-10. 2000
    2000 Nk Cell and Ctl Activities Can Be Raised Via Conditioning of the Cns with Unrelated Unconditioned Stimuli: NeuroimmunomodulationInternational Journal of Neuroscience.  103:79-89. 2000
    1999 Psychoneuroendocrine immunology: Perception of stress can alter body temperature and natural killer cell activityInternational Journal of Neuroscience.  98:95-129. 1999
    1997 Afferent signals to the cns appear not to condition the modulation of lnterleukin-1 receptors in the hippocampusNeuroimmunomodulation.  4:298-304. 1997
    1997 Psychoneuroendocrine immunology: Site of recognition, learning and memory in the immune system and the brainInternational Journal of Neuroscience.  92:259-286. 1997
    1996 Involvement of cytokine gene expression in the age-dependent decline of NK cell responseCellular Immunology.  173:221-229. 1996
    1996 Activation of γ-opioid receptors are required for the conditioned enhancement of NK cell activityBrain Research.  737:263-268. 1996
    1996 Conditioning of Body Temperature and Natural Killer Cell Activity with Arecoline, a Muscarinic Cholinergic AgonistNeuroimmunomodulation.  3:233-238. 1996
    1996 Lipopolysaccharide and IL-1 α activate CNS pathways as measured by NK cell activityPhysiology and Behavior.  59:499-504. 1996
    1996 The use of conditioning to probe for CNS pathways that regulate fever and NK cell activityInternational Journal of Neuroscience.  84:229-245. 1996
    1995 Expression of the conditioned NK cell activity is β-endorphin dependentBrain Research.  678:76-82. 1995
    1995 Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activityJournal of Neuroimmunology.  59:57-63. 1995
    1995 Conditioning of the secondary cytotoxic T-lymphocyte response to YC8 tumorPharmacology Biochemistry and Behavior.  50:399-403. 1995
    1994 Characterization of the synthesis and expression of the GTA-kinase from transformed and normal rodent cellsBBA - Gene Structure and Expression.  1218:375-387. 1994
    1994 Effect of dexamethasone on conditioned enhancement of natural killer cell activityNeuroimmunomodulation.  1:370-376. 1994
    1994 Efferent signal(s) responsible for the conditioned augmentation of natural killer cell activity.Neuroimmunomodulation.  1:74-81. 1994
    1994 Lidocaine interrupts the conditioned natural killer cell response by interfering with the conditioned stimulusNeuroimmunomodulation.  1:278-283. 1994
    1994 Role of arcuate nucleus of the hypothalamus in the acquisition of association memory between the CS and USJournal of Neuroimmunology.  50:109-114. 1994
    1994 Sodium carbonate prevents NK cell conditioning by interfering with the US signalInternational Journal of Neuroscience.  77:277-286. 1994
    1994 Use of an allogeneic antigen to induce resistance and regression of an autologous tumorJournal of Immunotherapy.  15:202-211. 1994
    1993 A multiple modality approach combining the effect of conditioning with adoptive chemoimmunotherapyInternational Journal of Neuroscience.  71:251-265. 1993
    1993 Conditioning of the allogeneic cytotoxic lymphocyte responsePharmacology Biochemistry and Behavior.  44:275-280. 1993
    1993 Identification of specific pathways of communication between the CNS and NK cell systemLife Sciences.  53:527-540. 1993
    1993 The identity of the unconditioned stimulus to the central nervous system is interferon-βJournal of Neuroimmunology.  45:75-81. 1993
    1992 The central effect of methionine-enkephalin on NK cell activityBrain Research.  578:142-148. 1992
    1992 A Simple, Single, Trial-Learning Paradigm for Conditioned Increase in Natural Killer Cell ActivityProceedings of the Society for Experimental Biology and Medicine.  199:199-203. 1992
    1992 Acquisition of enhanced natural killer cell activity under anesthesiaLife Sciences.  50:2067-2074. 1992
    1992 Indomethacin and sodium carbonate effects on conditioned fever and NK cell activityPharmacology Biochemistry and Behavior.  43:417-422. 1992
    1992 The direction of the conditioned natural killer cell response can be re-directed with indomethacin and/or handlingInternational Journal of Neuroscience.  67:229-239. 1992
    1991 A behavioral augmentation of natural immunity: Odor specificity supports a pavlovian conditioning modelInternational Journal of Neuroscience.  61:277-288. 1991
    1991 Conditioning the elevation of body temperature, a host defensive reflex responseLife Sciences.  49:93-99. 1991
    1991 Effect of thymic hormone treatment on several immune functions of nude miceMechanisms of Ageing and Development.  58:245-254. 1991
    1991 In vivo enhancement of NK cell activity with met-enkephalin and glycyl-glutamine: Their possible role in the conditioned responseInternational Journal of Neuroscience.  61:135-143. 1991
    1991 Role of immune cells in the pavlovian conditioning of specific resistance to cancerInternational Journal of Neuroscience.  59:101-117. 1991
    1991 Survey of Thymic Hormone Effects on Physical and Immunological Parameters in C57BL/6NNia Mice of Different AgesAnnals of the New York Academy of Sciences.  621:239-255. 1991
    1990 Conditioning: A New Approach to ImmunotherapyCancer Research.  50:4295-4299. 1990
    1990 Characterization of 5b12.1, a monoclonal antibody specific for IL-6Growth Factors.  3:181-190. 1990
    1990 Effect of reserpine on retention of the conditioned NK cell responsePharmacology Biochemistry and Behavior.  36:51-56. 1990
    1990 Host response to myeloma: Effect of syngeneic spleen cells on the growth and functionof MOPC 104e myeloma in vitroCancer Investigation.  8:17-25. 1990
    1990 Thymic peptides as anti-aging drugs: Effect of thymic hormones on immunity and life spanInternational Journal of Neuroscience.  51:371-372. 1990
    1989 Immunoregulation of murine plasmacytoma II. Target selectivity of anomalous killer cells and role of immune t cells for the inductionCancer Investigation.  7:27-38. 1989
    1989 Immunoregulation of murine plasmacytoma i. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104eCancer Investigation.  7:17-26. 1989
    1989 In vitro and in vivo growth control of transformed lymphoid cells expressing plasma membrane galactosyltransferaseOncogene.  4:1337-1344. 1989
    1989 Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB c miceBrain, Behavior, and Immunity.  3:247-262. 1989
    1989 Regression of MOPC 104E plasmacytoma with monoclonal anti-idiotype antibodiesJournal of biological response modifiers.  8:385-396. 1989
    1988 Activation of natural killer cell function during interferon-α treatment of patients with condyloma acuminatum is predictive of clinical responseJournal of Biological Regulators and Homeostatic Agents.  2:63-66. 1988
    1988 Augmentation of Natural Immunity and Regulation of Tumor Growth by ConditioningAnnals of the New York Academy of Sciences.  521:29-42. 1988
    1988 Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-βJournal of Immunology.  140:661-665. 1988
    1988 Host response to myeloma: I. Induction of cytotoxic and suppressor t cells by in vivo immunization with MOPC 104e plasmacytomaCancer Investigation.  6:29-37. 1988
    1987 Conditioned enhancement of natural killer cell activity, but not interferon, with camphor or saccharin‐Licl conditioned stimulusJournal of Neuroscience Research.  18:10-15. 1987
    1987 Influence of Conditioned Natural Immunity on Tumor GrowthAnnals of the New York Academy of Sciences.  496:637-646. 1987
    1987 Modulation of immune response. A possible role for murine salivary epidermal and nerve growth factorsJournal of Periodontology.  58:498-500. 1987
    1987 Regulation of Natural Immunity (NK Activity) by ConditioningAnnals of the New York Academy of Sciences.  496:545-552. 1987
    1986 In Vitro Effect of Monoclonal Anti-ldiotype Antibodies (Anti-M104E) on MOPC 104E Myeloma CellsCancer Research.  46:1250-1254. 1986
    1986 Induction of the plateau phase and rescue of MOPC 104e by nonspecific immunizationCancer Investigation.  4:525-533. 1986
    1986 Spleen cell and thymocyte mitogen response in the presence of serum from castrate or intact male ratsContraceptive delivery systems.  2:248-255. 1986
    1985 Neural and environmental influences on neoplasia and conditioning of NK activityJournal of Immunology.  135. 1985
    1985 2,4-Diamino pteridine mustard: A new active-site-directed anticancer agentProceedings of the American Association for Cancer Research.  VOL. 26. 1985
    1985 Differential effects of monoclonal anti-idiotype antibodies on MOPC 104E myelomaFederation proceedings.  44. 1985
    1985 Effect of restraint stress and poly I:C on tumor growth and conditioning of NK activity (Pavlovian conditioning)Federation proceedings.  44. 1985
    1985 Establishment of growth factor-dependent MOPC 104E cell line in vitroCellular Immunology.  90:24-31. 1985
    1985 Host regulation of MOPC 104e plasmacytoma after reduction of tumor burden by total body irradiationCancer Investigation.  3:217-223. 1985
    1985 Induction of plateau phase and rescue of MOPC 104E by non-specific immunizationFederation proceedings.  44. 1985
    1985 Tumor burden, chemotherapy, and cell kill in osteosarcoma modelAmerican Journal of Clinical Oncology.  8:89-96. 1985
    1984 Inhibition of growth of MOPC 104E cells in immunosuppressed miceJournal of Immunology.  133:3424-3428. 1984
    1984 NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonancesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research.  805:104-116. 1984
    1984 Reduction of Tumor Burden in a Murine Osteosarcoma following Hyperthermia Combined with CyclophosphamideCancer Research.  44:1405-1408. 1984
    1984 Loss of High-Energy Phosphate following Hyperthermia Demonstrated by in Vivo 31P-Nuclear Magnetic Resonance SpectroscopyCancer Research.  44:633-638. 1984
    1984 Effect of thymic hormone treatment in Nu/Nu miceFederation proceedings.  43. 1984
    1984 Effects of orchiectomy on spleen cell mitogen response and on the thymus of aged miceExperimental Aging Research.  10:189-191. 1984
    1984 Growth factor dependent and growth factor independent MOPC 104E cell lines: Growth characteristics in vivo and in vitroFederation proceedings.  43. 1984
    1984 Natural suppressor factors in serum prevent generation of CTL in vivoFederation proceedings.  43. 1984
    1984 Regulation of mopc 104e by T cells and growth factors induced by C. Parvum stimulationInternational Journal of Cancer.  33:845-850. 1984
    1983 MOPC 104E Plasmacytoma functional heterogeneity and maturational potential in cultureCancer Research.  43:953-958. 1983
    1983 Tumor proliferation and chemotherapy in immunosuppressed miceCancer Research.  43:1097-1100. 1983
    1983 Alloreactivity. I. Effects of age and thymic hormone treatment on cell-mediated immunity in C57B1/6NNia miceMechanisms of Ageing and Development.  22:309-319. 1983
    1983 Investigation in the role of surgery, chemotherapy, and radiation in a murine osteosarcoma modelAmerican Journal of Clinical Oncology.  6:61-69. 1983
    1982 Mitogen response of peripheral blood and splenic lymphocytes and effect of 2-mercaptoethanol in tumor-bearing miceCancer Immunology, Immunotherapy.  12:225-230. 1982
    1982 Inhibitory Effect of L-Homoarginine on Murine Osteosarcoma cell proliferationCancer Research.  42:1072-1077. 1982
    1982 31P NMR spectroscopy of in vivo tumorsJournal of Magnetic Resonance (1969).  49:271-286. 1982
    1982 Antigenic determinants on lymphocytes from young and old C57BL/6 miceExperimental Gerontology.  17:375-381. 1982
    1982 Effects of aging and thymic hormone treatment on cell-mediated cytotoxicity in C57BL/6 miceFederation proceedings.  41:795. 1982
    1982 Enhancement of maze learning in old C57BL/6 mice by dietary lecithinNeurobiology of Aging.  3:223-226. 1982
    1982 Exploitable mechanisms in cancer therapyProceedings of the American Association for Cancer Research.  Vol. 23. 1982
    1982 Immunosuppressive effect of mouse serum lipoproteins. II. In vivo studiesJournal of Immunology.  128:2107-2110. 1982
    1981 Assessment of myeloma maintenance regimen of prednisone, adriamycin, imuran, and vincristine in a murine plasmacytoma modelCancer clinical trials.  4:135-141. 1981
    1981 Effect of Immune Response to Sheep Red Blood Cells on Plasmacytoma MOPC 104 ECancer Research.  41:2197-2199. 1981
    1981 Immunosuppressive effect of mouse serum lipoproteins. I. In vitro studiesJournal of Immunology.  126:1909-1913. 1981
    1980 A murine plasmacytoma model for screening active drugs for human myelomaCancer clinical trials.  3:395-402. 1980
    1980 Characterization of an auto-rosette inhibitory fraction in mouse serumJournal of Immunology.  125:1298-1301. 1980
    1980 Maintenance of MOPC 104E Myeloma in Plateau PhaseCancer Research.  40:2372-2376. 1980
    1980 Osteosarcoma Associated Alkaline Phosphatase and In Vivo Growth and DevelopmentProceedings of the Society for Experimental Biology and Medicine.  164:229-233. 1980
    1980 Regulation of MOPC 104E cells in vivo following chemotherapyFederation proceedings.  39:3115. 1980
    1980 Surgical adjuvant chemotherapy of metastatic murine osteosarcomaInternational Journal of Cancer.  25:393-397. 1980
    1979 A methodological approach to the prediction of anticancer drug effect in humansCancer Research.  39:402-407. 1979
    1979 Age related changes in auto-erythrocyte rosettes in the C57BL/6J and NZB/BINJ miceMechanisms of Ageing and Development.  11:45-54. 1979
    1979 Sequential appearance of auto-erythrocyte antibody immunoglobulin classes with ageJournal of Gerontology.  34:177-182. 1979
    1978 Tumor immunology of experimental osteosarcoma.Clinical Orthopaedics and Related Research.  246-260. 1978
    1978 Age dependent reaction of mouse thymus cells with autologous and syngeneic erythrocytesMechanisms of Ageing and Development.  8:329-339. 1978
    1978 Development of an in vitro assay of antineoplastic drug efficacy with tumor modelsProceedings of the American Association for Cancer Research.  Vol. 19. 1978
    1977 An Experimental Approach to Relate a Tumor-associated Enzyme Marker to Tumor Cell NumbersCancer Research.  37:365-368. 1977
    1977 Autoimmune disease antigensJournal of Oral Pathology and Medicine.  6:161-187. 1977
    1977 Cis-Dichlorodiammineplatinum(II) Chemotherapy in Experimental Murine Myeloma MOPC 104ECancer Research.  37:771-774. 1977
    1977 Drug evaluation with experimental murine myelomaProceedings of the American Association for Cancer Research.  Vol. 18. 1977
    1977 In vitro pharmacokinetics of a tumor model, MOPC 104E murine tumorFederation proceedings.  36. 1977
    1976 IgM complex receptors on subpopulations of murine lymphocytesJournal of Immunology.  116:1199-1203. 1976
    1976 Chemotherapy of multiple myeloma in experimental animalsProceedings of the American Association for Cancer Research.  Vol. 17. 1976
    1976 Immunologic Suppression of DNA Synthesis in MOPC 104E Plasmacytoma Cells (39490)Proceedings of the Society for Experimental Biology and Medicine.  153:107-111. 1976
    1976 Monitoring of Murine Osteosarcoma by Serial Alkaline Phosphatase DeterminationsJNCI: Journal of the National Cancer Institute.  57:837-839. 1976
    1975 Evaluation of a Cooperative Group Human Myeloma Protocol Using the MOPC 104E Myeloma ModelCancer Research.  35:1309-1313. 1975
    1975 Rat immunoglobulins in serum and secretions: Purification of rat IgM, IgA, and IgG and their quantitation in serum, colostrum, milk and salivaImmunochemistry.  12:817-823. 1975
    1974 Complement levels in malnourished animals: measurement of complement in rat milk during the period of lactationJournal of the Reticuloendothelial Society.  16:213-219. 1974
    1974 Complement levels in malnourished animals: quantification of serum complement in rat dams and their offspringJournal of the Reticuloendothelial Society.  16:204-212. 1974
    1974 Acid-catalyzed hydrolysis of maltose and cellobiose 1-phenylflavazolesCarbohydrate Research.  35:255-258. 1974
    1974 Chemotherapy and Rate of Kill of Tumor Cells in a Mouse PlasmacytomaCancer Research.  34:1738-1742. 1974
    1974 Measurement of antibody release from single cells. III. Rate of release of IgM from MOPC 104E plasmacytomaJournal of Immunology.  112:266-270. 1974
    1974 Quantitation of antigens by immunoelectrophoresisImmunochemistry.  11:305-308. 1974
    1974 Quantitation of total body tumor cells (MOPC 104E). I. Subcutaneous tumor modelJNCI: Journal of the National Cancer Institute.  52:1199-1202. 1974
    1974 Quantitation of total-body tumor cells (MOPC 104E). II. Ascites tumor modelJNCI: Journal of the National Cancer Institute.  53:767-771. 1974
    1973 A mathematical model for the quantitation of tumor and antibody forming cell populations within an animal's bodyJournal of Immunology.  111:1546-1553. 1973
    1973 Studies of MOPC 104E plasmacytoma cells forming rosettes with autologous and syngeneic erythrocytesJournal of Immunology.  111:893-899. 1973
    1973 A Modified Immunofluorescence Technique for Detection of Surface IgProceedings of the Society for Experimental Biology and Medicine.  144:225-228. 1973
    1973 Methodology a study of the single radial hemolysis in gel system-III. Quantitation of complementImmunochemistry.  10:645-649. 1973
    1973 Use of fluorescein conjugated dextran for the detection of MOPC 104E tumor cellsImmunochemistry.  10:51-53. 1973
    1972 Use of dextran-conjugated SRBC for the detection of MOPC 104E tumor cells.Journal of Immunology.  109:810-815. 1972
    1972 Use of dextran conjugated columns for the isolation of large quantities of MOPC 104E IgMImmunochemistry.  9. 1972

    Chapter

    Year Title Altmetric
    2018 Augmentation of natural immunity by conditioning and possible mechanisms of enhancement.  103-113. 2018

    Research Overview

  • My specific research interests are in:

    interaction between the immune system and the central nervous system conditioning and mild-to-moderate stress to study interactions between the immune system and the central nervous system, alterations in immune functions, and regulation of cancer/tumor growth; and alterations in immune cell populations and functions with age in mice.

    To gain knowledge about the above topics, our group has developed methodology to quantitate cancer/tumor burden in mice, determination of response of tumors to chemotherapy, immunotherapy, and combination of the both therapies. We have developed conditioning paradigm for an increase in natural killer cell activity and cytotoxic T-cell activity (immune functions) for cancer treatment therapeutic purposes in mice. We have investigated alterations in immune cells and their activities, following treatment with hormones produced by the thymus. We have measured age associated changes in immune cells and immune functions with age in mice.

    Immunology, Biology of Aging, Evolutionary Medicine
  • Teaching Activities

  • BY426 - Evolutionary Medicine (Spring Term 2019) 2019
  • BY440 - Immunology (Spring Term 2019) 2019
  • BY626 - Evolutionary Medicine (Spring Term 2019) 2019
  • BY640 - Immunology (Spring Term 2019) 2019
  • BY280 - Biology of Aging (Fall Term 2018) 2018
  • BY440 - Immunology (Fall Term 2018) 2018
  • BY540 - Biology of Aging (Fall Term 2018) 2018
  • BY640 - Immunology (Fall Term 2018) 2018
  • GER540 - Biology of Aging (Fall Term 2018) 2018
  • BY426 - Evolutionary Medicine (Spring Term 2018) 2018
  • BY440 - Immunology (Spring Term 2018) 2018
  • BY626 - Evolutionary Medicine (Spring Term 2018) 2018
  • BY640 - Immunology (Spring Term 2018) 2018
  • BY698 - Nonthesis Research (Spring Term 2018) 2018
  • BY280 - Biology of Aging (Fall Term 2017) 2017
  • BY440 - Immunology (Fall Term 2017) 2017
  • BY540 - Biology of Aging (Fall Term 2017) 2017
  • BY640 - Immunology (Fall Term 2017) 2017
  • BY698 - Nonthesis Research (Fall Term 2017) 2017
  • GER280 - Biology of Aging (Fall Term 2017) 2017
  • GER540 - Biology of Aging (Fall Term 2017) 2017
  • BY426 - Evolutionary Medicine (Spring Term 2017) 2017
  • BY440 - Immunology (Spring Term 2017) 2017
  • BY626 - Evolutionary Medicine (Spring Term 2017) 2017
  • BY280 - Biology of Aging (Fall Term 2016) 2016
  • BY440 - Immunology (Fall Term 2016) 2016
  • BY540 - Biology of Aging (Fall Term 2016) 2016
  • BY640 - Immunology (Fall Term 2016) 2016
  • GER280 - Biology of Aging (Fall Term 2016) 2016
  • GER540 - Biology of Aging (Fall Term 2016) 2016
  • BY397 - Advanced Directed Readings (Summer Term 2016) 2016
  • BY699 - Thesis Research (Summer Term 2016) 2016
  • BY426 - Evolutionary Medicine (Spring Term 2016) 2016
  • BY440 - Immunology (Spring Term 2016) 2016
  • BY626 - Evolutionary Medicine (Spring Term 2016) 2016
  • BY640 - Immunology (Spring Term 2016) 2016
  • BY699 - Thesis Research (Spring Term 2016) 2016
  • BY280 - Biology of Aging (Fall Term 2015) 2015
  • BY440 - Immunology (Fall Term 2015) 2015
  • BY540 - Biology of Aging (Fall Term 2015) 2015
  • BY640 - Immunology (Fall Term 2015) 2015
  • GER540 - Biology of Aging (Fall Term 2015) 2015
  • BY426 - Evolutionary Medicine (Spring Term 2015) 2015
  • BY440 - Immunology (Spring Term 2015) 2015
  • BY626 - Evolutionary Medicine (Spring Term 2015) 2015
  • BY640 - Immunology (Spring Term 2015) 2015
  • BY280 - Biology of Aging (Fall Term 2014) 2014
  • BY440 - Immunology (Fall Term 2014) 2014
  • BY540 - Biology of Aging (Fall Term 2014) 2014
  • BY640 - Immunology (Fall Term 2014) 2014
  • GER280 - Biology of Aging (Fall Term 2014) 2014
  • BY397 - Advanced Directed Readings (Spring Term 2014) 2014
  • BY426 - Evolutionary Medicine (Spring Term 2014) 2014
  • BY440 - Immunology (Spring Term 2014) 2014
  • BY626 - Evolutionary Medicine (Spring Term 2014) 2014
  • BY640 - Immunology (Spring Term 2014) 2014
  • BY699 - Thesis Research (Spring Term 2014) 2014
  • BY280 - Biology of Aging (Fall Term 2013) 2013
  • BY440 - Immunology (Fall Term 2013) 2013
  • BY540 - Biology of Aging (Fall Term 2013) 2013
  • BY640 - Immunology (Fall Term 2013) 2013
  • BY699 - Thesis Research (Fall Term 2013) 2013
  • GER540 - Biology of Aging (Fall Term 2013) 2013
  • BY682 - Seminar in Immunology (Summer Term 2013) 2013
  • BY782 - Seminar in Immunology (Summer Term 2013) 2013
  • BY426 - Evolutionary Medicine (Spring Term 2013) 2013
  • BY440 - Immunology (Spring Term 2013) 2013
  • BY626 - Evolutionary Medicine (Spring Term 2013) 2013
  • BY640 - Immunology (Spring Term 2013) 2013
  • BY280 - Biology of Aging (Fall Term 2012) 2012
  • BY440 - Immunology (Fall Term 2012) 2012
  • BY499 - Biology Seminar (Fall Term 2012) 2012
  • BY540 - Biology of Aging (Fall Term 2012) 2012
  • BY640 - Immunology (Fall Term 2012) 2012
  • BY682 - Seminar in Immunology (Fall Term 2012) 2012
  • BY782 - Seminar in Immunology (Fall Term 2012) 2012
  • GER280 - Biology of Aging (Fall Term 2012) 2012
  • GRD600 - Core Issues in Aging (Fall Term 2012) 2012
  • GRD600 - Core Issues in Aging (Summer Term 2012) 2012
  • BY426 - Evolutionary Medicine (Spring Term 2012) 2012
  • BY440 - Immunology (Spring Term 2012) 2012
  • BY626 - Evolutionary Medicine (Spring Term 2012) 2012
  • BY640 - Immunology (Spring Term 2012) 2012
  • BY280 - Biology of Aging (Fall Term 2011) 2011
  • BY440 - Immunology (Fall Term 2011) 2011
  • BY540 - Biology of Aging (Fall Term 2011) 2011
  • BY640 - Immunology (Fall Term 2011) 2011
  • BY280 - Biology of Aging (Summer Term 2011) 2011
  • BY499 - Biology Seminar (Summer Term 2011) 2011
  • BY540 - Biology of Aging (Summer Term 2011) 2011
  • BY682 - Seminar in Immunology (Summer Term 2011) 2011
  • BY782 - Seminar in Immunology (Summer Term 2011) 2011
  • GER280 - Biology of Aging (Summer Term 2011) 2011
  • BY426 - Evolutionary Medicine (Spring Term 2011) 2011
  • BY440 - Immunology (Spring Term 2011) 2011
  • BY626 - Evolutionary Medicine (Spring Term 2011) 2011
  • BY640 - Immunology (Spring Term 2011) 2011
  • BY280 - Biology of Aging (Fall Term 2010) 2010
  • BY440 - Immunology (Fall Term 2010) 2010
  • BY540 - Biology of Aging (Fall Term 2010) 2010
  • BY640 - Immunology (Fall Term 2010) 2010
  • GER540 - Biology of Aging (Fall Term 2010) 2010
  • BY280 - Biology of Aging (Summer Term 2010) 2010
  • BY499 - Biology Seminar (Summer Term 2010) 2010
  • BY540 - Biology of Aging (Summer Term 2010) 2010
  • BY682 - Seminar in Immunology (Summer Term 2010) 2010
  • GER540 - Biology of Aging (Summer Term 2010) 2010
  • BY426 - Evolutionary Medicine (Spring Term 2010) 2010
  • BY440 - Immunology (Spring Term 2010) 2010
  • BY499 - Biology Seminar (Spring Term 2010) 2010
  • BY626 - Evolutionary Medicine (Spring Term 2010) 2010
  • BY640 - Immunology (Spring Term 2010) 2010
  • BY685 - Seminar in Cell Biology (Spring Term 2010) 2010
  • BY785 - Seminar in Cell Biology (Spring Term 2010) 2010
  • BY440 - Immunology (Fall Term 2009) 2009
  • BY640 - Immunology (Fall Term 2009) 2009
  • BY280 - Biology of Aging (Summer Term 2009) 2009
  • BY499 - Biology Seminar (Summer Term 2009) 2009
  • BY540 - Biology of Aging (Summer Term 2009) 2009
  • BY682 - Seminar in Immunology (Summer Term 2009) 2009
  • GER540 - Biology of Aging (Summer Term 2009) 2009
  • BY440 - Immunology (Spring Term 2009) 2009
  • BY499 - Biology Seminar (Spring Term 2009) 2009
  • BY640 - Immunology (Spring Term 2009) 2009
  • BY682 - Seminar in Immunology (Spring Term 2009) 2009
  • BY782 - Seminar in Immunology (Spring Term 2009) 2009
  • BY440 - Immunology (Fall Term 2008) 2008
  • BY640 - Immunology (Fall Term 2008) 2008
  • BY280 - Biology of Aging (Summer Term 2008) 2008
  • BY499 - Biology Seminar (Summer Term 2008) 2008
  • BY540 - Biology of Aging (Summer Term 2008) 2008
  • BY694 - Seminar in Microbiology (Summer Term 2008) 2008
  • BY794 - Seminar in Microbiology (Summer Term 2008) 2008
  • GER280 - Biology of Aging (Summer Term 2008) 2008
  • BY440 - Immunology (Spring Term 2008) 2008
  • BY499 - Biology Seminar (Spring Term 2008) 2008
  • BY640 - Immunology (Spring Term 2008) 2008
  • BY685 - Seminar in Cell Biology (Spring Term 2008) 2008
  • BY440 - Immunology (Fall Term 2007) 2007
  • BY499 - Biology Seminar (Fall Term 2007) 2007
  • BY640 - Immunology (Fall Term 2007) 2007
  • BY685 - Seminar in Cell Biology (Fall Term 2007) 2007
  • BY785 - Seminar in Cell Biology (Fall Term 2007) 2007
  • Education And Training

  • Doctor of Philosophy in Biochemistry, Southern Illinois University System : Carbondale 1970
  • Full Name

  • Vithal Ghanta